| 1 |
34387452 | [Blockade of D1-like dopaminergic receptors suppresses Th17-cell function in multiple sclerosis]. | 2021 |
1 |
| 2 |
28940477 | cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms. | 2018 Mar |
2 |
| 3 |
24711809 | The dopaminergic system in autoimmune diseases. | 2014 |
1 |
| 4 |
24057505 | Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals. | 2013 Oct |
1 |
| 5 |
21307293 | Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model. | 2011 Mar 15 |
2 |
| 6 |
19332443 | Dopamine released by dendritic cells polarizes Th2 differentiation. | 2009 Jun |
2 |
| 7 |
15240805 | Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration. | 2004 Jul 7 |
1 |
| 8 |
11435749 | Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism. | 2001 |
4 |
| 9 |
11460316 | Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis. | 2001 Jul |
2 |
| 10 |
10771134 | The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging. | 2000 Apr 14 |
1 |
| 11 |
8011238 | Cerebrospinal fluid dopamine in HIV-1 infection. | 1994 Jan |
1 |